Holen Sie sich die Stockscreener-App
256.56
12.26%
-35.86
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
Bio-Rad Laboratories Q4 2025 sales up 9% to USD 693.2M - Medical Buyer
Bio-Rad Laboratories (NYSE:BIO) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Beyond the Balance Sheet: What SWOT Reveals About Bio-Rad Labora - GuruFocus
Bio-Rad Q4 2025 slides reveal modest growth amid segment divergence and strategic shifts - Investing.com Nigeria
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap DownHere's What Happened - MarketBeat
Bio-Rad Laboratories Inc (BIO) Shares Down 11.17% on Feb 13 - GuruFocus
Oversold Conditions For Bio-Rad Laboratories (BIO) - Nasdaq
Bio-Rad Laboratories (BIO) Shares Cross Below 200 DMA - Nasdaq
Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down After Earnings Miss - MarketBeat
Pinterest Posts Downbeat Results, Joins DraftKings, Toast, Expedia And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
S&P 500 Futures Drop in Premarket Trading; Pinterest, Bio-Rad Labs A Lag - Barron's
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
BIO-RAD LABORATORIES, INC. SEC 10-K Report - TradingView
Bio-Rad (BIO) Reports Q4 Revenue Growth and Strategic Initiatives - GuruFocus
Bio-Rad Laboratories, Inc. $BIO Holdings Lifted by Envestnet Asset Management Inc. - MarketBeat
Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements - MSN
Bio-Rad Laboratories Q4 2025 Earnings Call Transcript - MarketBeat
Bio-Rad Laboratories Q4 Earnings Call Highlights - Yahoo Finance
Bio-Rad Laboratories (NYSE:BIO.B) Posts Quarterly Earnings Results - MarketBeat
Bio-Rad (BIO) Q4 2025 Earnings Call Transcript - AOL.com
Bio-Rad: Q4 Earnings Snapshot - kare11.com
BIO: 2025 results met guidance with diagnostics growth, ddPCR momentum, and cautious 2026 outlook - TradingView
BIO: 2025 saw resilient revenue and cash flow, with diagnostics growth and ddPCR momentum offsetting margin pressures - TradingView
Earnings call transcript: Bio-Rad Labs Q4 2025 misses EPS expectations - Investing.com India
Bio-Rad: Fourth Quarter Financial Highlights - Bitget
Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates - Yahoo Finance
Bio-Rad Laboratories Swings To Q4 Profit - Nasdaq
Bio-Rad shares tumble as Q4 earnings miss expectations By Investing.com - Investing.com Australia
Bio-Rad Laboratories Posts Mixed Q4 2025 Financial Results - TipRanks
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q4 Revenue $693.2M, vs. FactSet Est of $688.8M - marketscreener.com
Bio-Rad Laboratories (NYSE:BIO) Announces Quarterly Earnings Results - MarketBeat
Is Bio Rad Laboratories Inc. stock risky to hold now2025 Analyst Calls & Verified Momentum Watchlists - mfd.ru
Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results - Business Wire
Bio-Rad earnings on deck as estimates drift lower ahead of report By Investing.com - Investing.com South Africa
Bio-Rad earnings on deck as estimates drift lower ahead of report - Investing.com UK
Is Bio Rad Laboratories Inc.’s ROE strong enough2025 Volatility Report & Capital Efficiency Focused Ideas - mfd.ru
Is Bio Rad Laboratories Inc. (BUWA) stock a safe buy pre earnings2025 Top Gainers & Expert Curated Trade Ideas - mfd.ru
Can Bio Rad Laboratories Inc. (BUW) stock sustain revenue momentumTrade Risk Summary & Daily Oversold Stock Bounce Ideas - mfd.ru
Dematic Automation Solution Drives Precision and Productivity for BIO-RAD Singapore - iTWire
Bio-Rad receives AOAC international validation for EZ-Check Listeria spp. and EZ-Check Listeria monocytogenes Testing Kits - Cambridge Network
Medical Biosensors Market is expected to reach US$ 12.60 Billion - openPR.com
Allianz Asset Management GmbH Boosts Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad EZ-Check Listeria Test Kits Receive AOAC Validation - Food Safety Magazine
Multiplex Immunoassays Market to Reach US$ 6.90 Billion by 2033 - openPR.com
Atlantic Union Bankshares Corp Purchases Shares of 4,099 Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories (BIO) Projected to Post Earnings on Thursday - MarketBeat
The Latest in ddPCR Technology - the-scientist.com
PCR Technologies Market Is Going to Boom |• Thermo Fisher Scientific • Bio-Rad Laboratories - openPR.com
Polymerase Chain Reaction Market Set for Rapid Growth and Trend - openPR.com
United States Digital PCR Market to Reach at 7.4% CAGR by 2031; - openPR.com
DNA Sequencing Market Covering Prime Factors and Competitive - openPR.com
Mawer Investment Management Ltd. Reduces Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Veritas Asset Management LLP Has $236.66 Million Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Chromatography Research Report 2026 - GlobeNewswire Inc.
Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026 - BioSpace
Universal Beteiligungs und Servicegesellschaft mbH Has $3.63 Million Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
North America Gas Chromatography Market Forecast Report - GlobeNewswire
North America Gas Chromatography Market Forecast Report 2025-2033 Featuring Agilent, Bio-Rad, Chromatotec, Merck, PerkinElmer, Phenomenex, Restek, Shimadzu, Thermo Fisher Scientific, Waters - Yahoo Finance Singapore
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):